Pharmaceutical companies lost more than 3.5 billion de-market hundreds of billions of "pharmaceutical Maotai" suddenly fell to a halt

days ago, the market value of 100 billion "Pharma Maotai" Changchun high-rise share price suddenly stopped, four days of market value evaporated more than 20 billion; Machine was delisted by the Shenzhen Stock Exchange, a record decline in A-shares, plummeted 99.75 percent, data show that chiyama machine has nearly 50,000 shareholders, in recent years, the company is deeply involved in annual report fraud, occupation of funds, the last three years of net profit losses totaled more than 3.5 billion yuan, and now in the capital market finally ended in de-listing. At present, the A-share market, Hengrui Pharmaceuticals, Meirui Medical, Pharmaceutical Mingkangde, Zhifei Biological, Chipoand other 10 pharmaceutical stock market value of more than 100 billion scale. As of the close of trading on September 18, Hengrui Pharmaceuticals was still in the top spot with a market capitalization of 472.2 billion yuan, followed by Meirui Medical, and the market capitalization ofexceeded that of Yunnan White Pharmaceuticals to become the leading market capitalization of the Chinese medicine sector.Pharmaceutical stocks TOP20 ranking changes! Hengrui retreated to a market capitalization of 470 billion yuan, "Chinese medicine stocks a brother" easy ownerIn November 2017, Hengrui Pharmaceuticals became the first pharmaceutical stocks with a market capitalization of more than 200 billion yuan; In June, the market value exceeded 300 billion yuan, in October 2019, the market value broke through 400 billion yuan, and in June this year, the market value of a new high exceeded the 500 billion mark, firmly in the "pharmaceutical stocks" throne. Recently, various sectors of the A-share market showed varying degrees of correction, as of the close of September 18, Hengrui Pharmaceutical market value fell back to 472.2 billion yuan, up more than 20% so far this year.The market value of Murray Healthcare has soared by more than 170 billion yuan so far this year, and the gap between the market capitalisation of Hengrui Pharmaceuticals and Meirui Medical has narrowed from more than 160 billion yuan to less than 80 billion yuan compared with last year. According to the data, Meirui Medical landed on A-shares in October 2018, with a market capitalization of more than 200 billion yuan a year after listing; By the close of trading on September 18th, the market value of Myer Healthcare had fallen back to $393.7 billion.In addition, "Chinese medicine stocks a brother" easy owner, in early September, the market value of theonce exceeded 160 billion yuan, this year has surged nearly 100 billion yuan, and then fell back to 147.4 billion yuan, surpassing Yunnan white medicine, become the market value of the Chinese medicine sector leader. (Minenet)